| Brittany Schulte, DNP, WHNP-BC | |
|
6301 S Mcclintock Dr Ste 215, Tempe, AZ 85283-3394 | |
| (480) 820-6657 | |
| Not Available |
| Full Name | Brittany Schulte |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 6301 S Mcclintock Dr Ste 215, Tempe, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598373995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 243799 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Contemporary Women's Care Pc | 0648256156 | 23 |
News Archive
Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.
NanoBio Corporation announced today that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus (RSV) vaccine have been published in PLoS One, an international peer-reviewed online publication.
Findings from a new global study suggest that estimates of gender-based violence prevalence based on health systems data or on police reports may underestimate the actual total prevalence by 11- to 128-fold. Led by Tia Palermo, PhD, Assistant Professor in Public Health and the Department of Preventive Medicine at Stony Brook University School of Medicine, the study is soon to be published online in the American Journal of Epidemiology.
Galderma Laboratories has announced FDA approval of a new product for the topical treatment of the inflammatory lesions of rosacea. MetroGel (metronidazole) Topical Gel, 1% will be available by prescription July 29, 2005. The new medication incorporates a higher concentration of metronidazole in a new, technologically advanced vehicle.
› Verified 4 days ago
| Entity Name | Southwest Contemporary Women's Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396746624 PECOS PAC ID: 0648256156 Enrollment ID: O20040625000646 |
News Archive
Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.
NanoBio Corporation announced today that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus (RSV) vaccine have been published in PLoS One, an international peer-reviewed online publication.
Findings from a new global study suggest that estimates of gender-based violence prevalence based on health systems data or on police reports may underestimate the actual total prevalence by 11- to 128-fold. Led by Tia Palermo, PhD, Assistant Professor in Public Health and the Department of Preventive Medicine at Stony Brook University School of Medicine, the study is soon to be published online in the American Journal of Epidemiology.
Galderma Laboratories has announced FDA approval of a new product for the topical treatment of the inflammatory lesions of rosacea. MetroGel (metronidazole) Topical Gel, 1% will be available by prescription July 29, 2005. The new medication incorporates a higher concentration of metronidazole in a new, technologically advanced vehicle.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Schulte, DNP, WHNP-BC 15404 S 13th Ave, Phoenix, AZ 85045-1944 Ph: (907) 687-4073 | Brittany Schulte, DNP, WHNP-BC 6301 S Mcclintock Dr Ste 215, Tempe, AZ 85283-3394 Ph: (480) 820-6657 |
News Archive
Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.
NanoBio Corporation announced today that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus (RSV) vaccine have been published in PLoS One, an international peer-reviewed online publication.
Findings from a new global study suggest that estimates of gender-based violence prevalence based on health systems data or on police reports may underestimate the actual total prevalence by 11- to 128-fold. Led by Tia Palermo, PhD, Assistant Professor in Public Health and the Department of Preventive Medicine at Stony Brook University School of Medicine, the study is soon to be published online in the American Journal of Epidemiology.
Galderma Laboratories has announced FDA approval of a new product for the topical treatment of the inflammatory lesions of rosacea. MetroGel (metronidazole) Topical Gel, 1% will be available by prescription July 29, 2005. The new medication incorporates a higher concentration of metronidazole in a new, technologically advanced vehicle.
› Verified 4 days ago
Candace Lew, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6301 S. Mcclintock Dr. #215, Kirsten Sorensen, Tempe, AZ 85283 Phone: 480-820-6657 Fax: 480-730-0803 | |
Dr. Kenneth James Busch, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2119 E Southern Ave, Tempe, AZ 85282 Phone: 480-831-1844 Fax: 480-383-2685 | |
Ali Baradaran, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2307 S Rural Rd, Tempe, AZ 85282 Phone: 480-491-5886 Fax: 480-491-3388 | |
Tiersa Hw Damore, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6301 S Mcclintock Dr, Suite 215, Tempe, AZ 85283 Phone: 480-820-6657 Fax: 480-730-0803 | |
Dr. H Randall Craig, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2155 E Conference Dr, Suite 115, Tempe, AZ 85284 Phone: 480-831-2445 Fax: 480-897-1283 | |
Callie Corrine Hurtt, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1634 S Priest Dr Ste 101, Tempe, AZ 85281 Phone: 480-821-3600 Fax: 480-857-2667 | |
Dr. Edward D Szmuc, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6301 S Mcclintock Dr Ste 215, Tempe, AZ 85283 Phone: 480-820-6657 Fax: 480-505-3689 |